One Experience for Molecular Imaging and Theranostics

Introducing MIM LesionID Pro* with Automated Pre-Processing

• Harness insights from quantitative biomarkers. 
• Assess patient therapy outcomes. 
• Boost confidence in treatment decisions and response monitoring. 
• Shorten time-to-report with AI-powered automation. 

*MIM LesionID Pro with automated pre-processing is not available for sale in the United States, Europe, Canada, or any other region. This is neither an offer nor an agreement to supply the technologies. Cannot be placed on the market or put into service until it has obtained all required regulatory authorizations. 

Efficiency at Every Step of the Patient Care Journey 

Implement personalized care on a single, comprehensive platform. From patient selection to therapy response monitoring to dosimetry and communicating outcomes, MIM Theranostics Solutions help make the promise of precision with Theranostics attainable.

• MIM LesionID^™ Pro: Aids treatment decision-making and response monitoring
• MIM SurePlan^™ MRT: Single time-point and multi-time-point dosimetry 
• MIM Encore^™: Comprehensive single platform for post-processing, reading, analysis, and collaboration 

Flexible Workflow Automation and Standardization

Handle increasing caseloads with an intuitive vendor-neutral platform for viewing, advanced quantitation, collaboration, and data management. 

• MIM Encore: Comprehensive single platform for post-processing, reading, analysis, and collaboration  
• MIMneuro^™: Brain imaging and quantitative analysis with multi-tracer support
• MIM SurePlan^™ LiverY90: Time-saving tools for liver and tumor segmentation, deformable registration, and posttreatment dosimetry using Y90-PET and Bremsstrahlung SPECT